Stop data brokers from exposing your personal information. Go to my sponsor: to get a 14-day free trial and see how much of yours is being sold. Then learn about the NEW BEST Priority Pass Credit Card ...

Background Racial and ethnic disparities in infectious disease burden have been reported in the USA and globally, most recently during the COVID-19 pandemic. It remains unclear whether such ...

Despite efforts to advance universal health coverage (UHC) in different contexts, evidence gaps remain, and implementation ...

The promising results, along with a separate FDA decision, could signal a major expansion of the use of the two companies' ...

The Quantum Frederick data center campus is one of six projects selected as part of a pilot program to expedite Maryland’s permitting review process, the office of Gov. Wes Moore announced on Tuesday.

Epkinly with Rituxan and Revlimid, compared to Rituxan and Revlimid alone, reduced risk of progression or death by 79%.

Epcoritamab shows promising results in treating relapsed follicular lymphoma, with FDA priority review for a groundbreaking ...

The Town Board agreed Tuesday to scrap a companion statement to the New York State “Pro-Housing Community” agreement that had ...

The Trump administration’s move to reduce requirements has puzzled some legal experts while drawing applause from oil states.

Net loss per share (GAAP) was $0.62, but remained negative as the company continues to invest heavily in research and development. The pivotal Phase 2 trial for Danon disease was placed on clinical ...

Kura Oncology missed GAAP revenue estimates in Q2 2025. Ziftomenib advanced to FDA Priority Review, hitting key clinical and regulatory milestones, with no product sales yet. Research and ...

At the 2025 EHA Congress, Dr. Harry Erba of Duke University presented Phase Ia/Ib data from the KOMET-007 trial testing ziftomenib at a 600-milligram once-daily dose plus intensive chemotherapy in ...